Program at a Glance

Led by a team of global experts, this premier AACE education event in the MENA will feature innovative educational experiences and highlight patient-centered approaches on the critical aspects of obesity, dyslipidemia, NAFLD, diabetes management, pituitary tumors, thyroid cancer, bone metabolism and more. The conference will allow attendees to optimize and personalize their patient outcomes by immersing themselves in the most relevant clinical approaches and technology advances. The education program will host world-renowned endocrinology and metabolism experts and include state-of-the-art symposia, general sessions, abstract presentations, as well as in-person networking opportunities with colleagues and industry professionals.

The Third edition of the conference will be held on November 17-19, 2023 at the Grand Hyatt Hotel in Dubai.

The Conference has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12 European CME credits (ECMEC®s). and 17.5 CME Credits from Dubai Health Authority

View Program

Expected Educational Outcomes

  • Evaluate the benefits of GLP-1 agonists and SGLT2-inhibitors beyond glucose management, and review tools to individualize type 2 diabetes management.
  • Show an understanding of evaluation and management of endocrine diseases during pregnancy and appreciate potential maternal and fetal outcomes of endocrine therapies.
  • Review the optimal clinical environment for screening and confirming the presence of endocrine hypertension, including primary aldosteronism, and understand the pitfalls in localizing an aldosterone-producing-adenoma.
  • Appraise the current literature on pharmacologic treatment of obesity and NAFLD in children and adults with and without prevalent diabetes.
  • Demonstrate appreciation of the controversies around the role of vitamin D supplementation in the musculoskeletal system; review recent guidance on treatment of hypercalcemia of malignancy.

Learning Objectives

By the end of the meeting, participants will be able to:

  • Discuss the latest clinical practice guidelines on endocrine disorders, including diabetes mellitus, diabetes technology, obesity, pituitary and adrenal disorders, thyroid cancer and bone metabolism.
  • Summarize key characteristics of evidence-based assessment and management options for patients with endocrine disorders and endocrine neoplasia.
  • Apply multidisciplinary approaches on the management and treatment options for patients with endocrine disorders for improved patient outcomes.
  • Formulate management plans that include optimal team-based, patient centered care of patients with endocrine disorders.

Target Audiences

This program targets all medical professionals that care for patients with endocrine disorders throughout the lifespan. This includes endocrinologists, cardiologists, nephrologists, primary care and family physicians, obstetricians and maternofetal specialists, pediatricians, advanced providers, nurses, diabetes educators, and pharmacists. The program is also intended for health care professionals at any stage in their career

Education Content Themes

  • Diabetes Management
  • Diabetes Technology
  • Endocrine Disorders during Pregnancy
  • Pediatric Endocrinology
  • Reproductive Endocrinology
  • Thyroid Disorders
  • Bone and Mineral Metabolism
  • Pituitary and Adrenal Disorders
  • Endocrine Neoplasia
  • NASH and Nonalcoholic Fatty Liver Disease (NAFLD)

Education Delivery Formats

  • General sessions using case-based learning, ARS, interactive group discussions
  • Sessions will be in-person
  • Meet the expert sessions
  • Plenary lectures

View Program